rm-493 and lonafarnib

rm-493 has been researched along with lonafarnib* in 1 studies

Other Studies

1 other study(ies) available for rm-493 and lonafarnib

Article	Year
New Drugs for Rare Disorders. The American journal of nursing, 2021, 02-01, Volume: 121, Issue:2 Several new drugs have been approved to treat rare genetic disorders: setmelanotide for certain conditions causing obesity; lumasiran for primary hyperoxaluria type 1, a kidney disorder; and lonafarnib for two diseases that cause premature aging. Topics: alpha-MSH; Anti-Obesity Agents; Humans; Piperidines; Progeria; Pyridines; Rare Diseases	2021

Article

Year

The American journal of nursing, 2021, 02-01, Volume: 121, Issue:2

Several new drugs have been approved to treat rare genetic disorders: setmelanotide for certain conditions causing obesity; lumasiran for primary hyperoxaluria type 1, a kidney disorder; and lonafarnib for two diseases that cause premature aging.

Topics: alpha-MSH; Anti-Obesity Agents; Humans; Piperidines; Progeria; Pyridines; Rare Diseases

2021